ライブ
eLifeMaterial damage to multielectrode arrays after electrolytic lesioning is insignificantFierceBiotechHow data-driven diagnostic lab services drive precise clinical trial enrollmentFierceBiotechRedefining what success looks like in PSC: The evolution of clinical trial endpointsBioPharma DiveModerna flu vaccine wins unanimous support from FDA panelFierceBiotechModerna’s flu candidate sails through FDA advisory committee in unanimous votesEndpoints NewsFDA vaccine advisors unanimously support Moderna's flu shotScienceWolves are reconquering Europe. Can people learn to live with them?Clinical OMICsPakistan’s Massive Genetic Database Reveals Millions of Unique VariantsClinical OMICsFirst Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase IIIBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-June 18, 2026Endpoints NewsTreasury weighs screening investments in China biotech
TSI Incorporated 2022年10月7日

TSI Incorporated Announces The Acquisition Of Casella From IDEAL Industries, Inc. - TheBigRedGuide.com

TSI Incorporated Announces The Acquisition Of Casella From IDEAL Industries, Inc. - TheBigRedGuide.com

原文
本文は利用できません。元の情報源をご確認ください。